An Observational Registry Using Drug Eluting Stents (DES) in Patients in a Real-World Setting (DEScover Registry).
Completed
Conditions studied: Cardiovascular Diseases, Vascular Disease, Arterial Occlusive Disease, Arteriosclerosis, Atherosclerosis
In brief
The DEScover Registry is designed to observe the results of using Drug Eluting Stents (DES) in patients in a real-world setting. The stents being observed are not investigational, that is, they have been approved for use in the general population.
Key facts
- Study ID
- NCT00489320
- Run by
- Cordis US Corp.
- People needed
- 7759
- Starts
- 2004-12-01
- Expected to finish
- 2006-07-01
- Last updated by the study team
- 2007-08-02
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Consecutive patients undergoing percutaneous coronary intervention at an enrolling center by study investigators
You may not qualify if…
- Patient refusal or inability to provide written informed consent and/or HIPAA authorization
Where it is running
- Rhode Island Hospital — Providence, Rhode Island, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.